Recent insights into Fc-mediated effector responses to HIV-1.

Current Opinion in HIV and AIDS
Margaret C Carpenter, Margaret E Ackerman

Abstract

Recent work defining Fc-mediated effector functions for both viral control and protection against infection is summarized and considered along with new strategies to drive robust Fc-mediated responses. In new human and nonhuman primate (NHP) vaccine trials as well as studies of natural infection, Fc-mediated effector responses have sometimes been observed to correlate with decreased risk of infection or with better clinical outcomes, suggesting a potential role for these responses in HIV-1 prevention and therapy. Recent highlights include use of antibody-dependent cellular cytotoxicity-sensitizing CD4-induced mimetic compounds, novel V1V2 immunogens, passive transfer studies, and vaccine regimens that successfully elicited Fc-mediated responses and were reported to decrease risk of infection in challenge studies in NHPs. Lastly, detailed studies of IgG3 forms of HIV-specific antibodies have reported that both neutralizing and Fc-mediated responses can be increased relative to the more prevalent IgG1 subclass. Successful harmonization of neutralizing and Fc-mediated responses may make key contributions to the goal of reducing HIV-1 infection via active and passive vaccination. New studies continue to highlight the importance of ...Continue Reading

References

Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
Mar 22, 2014·Science Translational Medicine·Nicole L YatesGeorgia D Tomaras
May 31, 2016·Nature Medicine·Monica VaccariGenoveffa Franchini
Mar 23, 2017·The Journal of Infectious Diseases·Supachai Rerks-NgarmUNKNOWN RV305 Study Team
Jun 9, 2017·Nature Communications·Todd BradleyBarton F Haynes
Aug 2, 2017·Cell·Joshua A HorwitzMichel C Nussenzweig
Nov 23, 2017·Trends in Microbiology·Jonathan RichardAndrés Finzi
Dec 19, 2017·PLoS Pathogens·Meredith E Davis-GardnerMichael Farzan
Jan 13, 2018·Scientific Reports·Preetha BalasubramanianCatarina E Hioe
Apr 2, 2018·Journal of Immunological Methods·Matthew J WorleyAmy W Chung
Aug 24, 2018·Retrovirology·Matthew S ParsonsStephen J Kent
Sep 22, 2018·Journal of Immunological Methods·Simone I RichardsonLynn Morris
Nov 27, 2018·The Journal of Clinical Investigation·Matthew S ParsonsStephen J Kent
Dec 18, 2018·Journal of Innate Immunity·Rebecca L R PowellSusan Zolla-Pazner
Feb 13, 2019·Trends in Immunology·Timon DamelangAmy W Chung
Feb 20, 2019·PLoS Pathogens·Katherine L WilliamsJulie Overbaugh
Apr 12, 2019·Cell Host & Microbe·Nirmin AlsahafiJames B Munro
May 3, 2019·Molecular Systems Biology·Srivamshi PittalaChris Bailey-Kellogg
May 30, 2019·Frontiers in Immunology·Michael TuenRalf Duerr

❮ Previous
Next ❯

Citations

Aug 7, 2021·Frontiers in Immunology·Stephen R Walsh, Michael S Seaman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.